Vyteris, Inc.

Vyteris, Inc.

Vyteris believes its method of drug delivery is jolting. Vyteris company is developing transdermal drug delivery systems that get medicine into the patient's system without needles. Its delivery system uses low-level electrical stimulation to inject topical medications into patients. Vyteris already has one FDA-approved product: LidoSite is a topical analgesic distributed by B. Braun Medical and LabCorp. Vyteris company is developing a peptide delivery system through a partnership with Ferring Pharmaceuticals. Entrepreneur Kevin Kimberlin owns a controlling interest in the company.

Contact Details

Office Address

Vyteris, Inc.
13-01 Pollitt Drive
Extension Fair Lawn, NJ, USA 07410
Phone: (201) 703-2299
Fax: (201) 703-2295

Executives

Chairman

Eugene A. Bauer

President and Director

Hartoun (Haro) Hartounian

Business Reviews for Vyteris, Inc.

Related Companies